Cargando…
From disease to treatment: from rare skeletal disorders to treatments for osteoporosis
During the past 15 years there has been an expansion of our knowledge of the cellular and molecular mechanisms regulating bone remodeling that identified new signaling pathways fundamental for bone renewal as well as previously unknown interactions between bone cells. Central for these developments...
Autores principales: | Appelman-Dijkstra, Natasha M., Papapoulos, Socrates E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879160/ https://www.ncbi.nlm.nih.gov/pubmed/26892377 http://dx.doi.org/10.1007/s12020-016-0888-7 |
Ejemplares similares
-
Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016) -
Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2015) -
Combination and sequential treatments in the management of osteoporosis
por: Papapoulos, Socrates
Publicado: (2012) -
Treatments of osteoporosis increase bone material strength index in patients with low bone mass
por: Schoeb, M., et al.
Publicado: (2020) -
Increased Bone Resorption during Lactation in Pycnodysostosis
por: Jansen, Ineke D.C., et al.
Publicado: (2021)